ReviewCancer management and research2025
Artificial Intelligence in Breast Cancer Diagnosis and Surgical Decision-Making: An Updated and Comprehensive Overview of Precision and Personalization in Current Evidence.
Review in Cancer management and research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Breast Cancer Surgery: Past, Present and Future-A Narrative Review.Journal of clinical medicine · 2026Review
- BrCaM an artificial intelligence model for surgical decision making in breast cancer.Scientific reports · 2026Article
- AI-powered robotic surgery: transforming surgical decisions.Journal of robotic surgery · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer (BC) surgery has been advanced through artificial intelligence (AI), which helps surgeons to gain more accurate results and apply surgical procedures. Despite the increasing focus on AI in BC management, there are knowledge gaps in the current understanding that can be readily identified from the existing works of literature. This narrative review aims to provide an update on the influencing role of AI technologies in precise and personalized clinical decision-making in BC surgery. We included articles published in English during the past 5 years from the major databases. Furthermore, this review used appropriate keywords with and without Boolean operators like "AND", "OR" and "NOT". We considered three major aspects for surgical practice: preoperative planning, intraoperative decision-making, and postoperative outcomes, while interpreting the studies. We found that AI-assisted BC surgery has advanced through the development of a new real-time, accurate tumor identifier, margin assessment, and robotic-assisted surgeries. Moreover, AI-based algorithms are gradually incorporated into the evaluation of the postoperative probability of reoccurrence, complications, and patient satisfaction. It is documented that integrating AI technologies into BC care is inevitable and set to expand further in all aspects. Furthermore, this review identified some major challenges in the algorithm and ethical aspects. The limitations, such as lack of external validation, integration barriers, and the "black box" nature of some AI models, remain unresolved. To fully utilize AI's capabilities, it is recommended that surgeons, AI developers, and policymakers collaborate on more advanced AI that is enhanced for personalized care by including patients' genetics, medical history, and lifestyle factors. Additionally, future prospective and exploratory cost-effective analysis studies are to be done.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.